The adult central nervous system has only a limited capacity for axonal regeneration. In this study, fibroblast growth factor-2 (FGF-2) was injected once into the spinal cord tissue around the injury site immediately after complete spinal cord transection in rats. This treatment markedly improved the locomotor function of the animals. Histological analysis demonstrated that tissue composed of FGF-2-induced fibronectin-positive cells (FIFs) had infiltrated the injury site and filled large cystic cavities, into which numerous axons with growth-associated protein-43 immunoreactivity penetrated. The FIFs could also be cultured from the intact spinal cord tissue, demonstrating that they were resident in the non-injured spinal cord. They had a spindle-shaped morphology and enhanced expression of mRNAs of N-cadherin and neurotrophic factors, suggesting the beneficial properties of the FIFs for axonal regeneration. Thus, these results argue for the continual use of autologous transplantation as a novel and promising cell therapy for the treatment of spinal cord injury.
Get full access to this article
View all access options for this article.
References
1.
NathanP.W. (1994). Effects on movement of surgical incisions into the human spinal cord. Brain, 117 (Pt. 2), 337–346.
2.
IannottiC., ZhangY.P., ShieldsL.B., HanY., BurkeD.A., XuX.M., and ShieldsC.B. (2006). Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J. Neurotrauma, 23, 853–865.
3.
FitchM.T., and SilverJ. (2008). CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp. Neurol., 209, 294–301.
4.
YiuG., and HeZ. (2006). Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci., 7, 617–627.
5.
HeZ., and KoprivicaV. (2004). The Nogo signaling pathway for regeneration block. Annu. Rev. Neurosci., 27, 341–368.
BulsaraK.R., IskandarB.J., VillavicencioA.T., and SkeneJ.H. (2002). A new millennium for spinal cord regeneration: growth‐associated genes. Spine, 27, 1946–1949.
8.
HarelN.Y., and StrittmatterS.M. (2006). Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?. Nat. Rev. Neurosci., 7, 603–616.
9.
HashimotoM., NittaA., FukumitsuH., NomotoH., ShenL., and FurukawaS. (2005a). Inflammation‐induced GDNF improves locomotor function after spinal cord injury. Neuroreport, 16, 99–102.
10.
HashimotoM., NittaA., FukumitsuH., NomotoH., ShenL., and FurukawaS. (2005b). Involvement of glial cell line‐ derived neurotrophic factor in activation processes of rodent macrophages. J. Neurosci. Res., 79, 476–487.
11.
SchnellL., SchneiderR., KolbeckR., BardeY.A., and SchwabM.E. (1994). Neurotrophin‐3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature, 367, 170–173.
12.
WidenfalkJ., LundstromerK., JubranM., BreneS., and OlsonL. (2001). Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J. Neurosci., 21, 3457–3475.
13.
Presta.M, Dell'EraP., MitolaS., MoroniE., RoncaR., and RusnatiM. (2005). Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev., 16, 159–178.
14.
GreenbergD.A., and JinK. (2005). From angiogenesis to neuropathology. Nature, 438, 954–959.
15.
NakatomiH., KuriuT., OkabeS., YamamotoS., HatanoO., KawaharaN., TamuraA., KirinoT., and NakafukuM. (2002). Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell, 110, 429–441.
16.
OhoriY., YamamotoS., NagaoM., SugimoriM., YamamotoN., NakamuraK., and NakafukuM. (2006). Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J. Neurosci., 26, 11948–11960.
17.
YoshimuraS., TeramotoT., WhalenM.J., IrizarryM.C., TakagiY., QiuJ., HaradaJ., WaeberC., BreakefieldX.O., and MoskowitzM.A. (2003). FGF‐2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J. Clin. Invest., 112, 1202–1210.
18.
AbeK., and SaitoH. (2001). Effects of basic fibroblast growth factor on central nervous system functions. Pharmacol. Res., 43, 307–312.
19.
BansalR. (2002). Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev. Neurosci., 24, 35–46.
20.
RabchevskyA.G., FugacciaI., Fletcher‐TurnerA., BladesD.A., MattsonM.P., and ScheffS.W. (1999). Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J. Neurotrauma, 16, 817–830.
21.
RabchevskyA.G., FugacciaI., TurnerA.F., BladesD.A., MattsonM.P., and ScheffS.W. (2000). Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp. Neurol., 164, 280–291.
Gómez‐PinillaF, VuL, and CotmanC.W. (1995). Regulation of astrocyte proliferation by FGF‐2 and heparan sulfate in vivo. J. Neurosci., 15, 2021–2029.
24.
WalzA., McFarlaneS, BrickmanY.G., NurcombeV., BartlettP.F., and HoltC.E. (1997). Essential role of heparan sulfates in axon navigation and targeting in the developing visual system. Development, 124, 2421–2430.
25.
SquiresC.H., ChildsJ., EisenbergS.P., PolveriniP.J., and SommerA. (1988). Production and characterization of human basic fibroblast growth factor from Escherichia coli. J. Biol. Chem., 263, 16297–16302.
26.
BassoD.M., BeattieM.S., and BresnahanJ.C. (1995). A sensitive and reliable locomotor 7. rating scale for open field testing in rats. J. Neurotrauma, 12, 1–21.
27.
NittaA., ItoM., FukumitsuH., OhmiyaM., ItoH., SometaniA., NomotoH., FurukawaY., and FurukawaS. (1999). 4‐Methylcatechol increases brain‐derived neurotrophic factor content and mRNA expression in cultured brain cells and in rat brain in vivo. J. Pharmacol. Exp. Ther., 291, 1276–1283.
28.
ItoH., NakajimaA., NomotoH., and FurukawaS. (2003). Neurotrophins facilitate neuronal differentiation of cultured neural stem cells via induction of mRNA expression of basic helix‐loop‐helix transcription factors Mash1 and Math1. J. Neurosci. Res., 71, 648–658.
29.
FurukawaS., and FurukawaY. (2007). FGF‐2‐treatment improves locomotor function via axonal regeneration in the transected rat spinal cord. Brain Nerve, 59, 1333–1339.
RiehlR., JohnsonK., BradleyR., GrunwaldG.B., CornelE., LilienbaumA., and HoltC.E. (1996). Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron, 17, 837–848.
32.
TomaselliK.J., NeugebauerK.M., BixbyJ.L., LilienJ., and ReichardtL.F. (1988). N‐cadherin and integrins: two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces. Neuron, 1, 33–43.
33.
Jimenez HamannM.C., TatorC.H., and ShoichetM.S. (2005). Injectable intrathecal delivery system for localized administration of EGF and FGF‐2 to the injured rat spinal cord. Exp. Neurol., 194, 106–119.
34.
KojimaA., and TatorC.H. (2002). Intrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats. J. Neurotrauma, 19, 223–238.
35.
GonzalezA.M., CarmanL.S., OngM., RayJ., GageF.H., ShultsC.W., and BairdA. (1994). Storage, metabolism, and processing of 125I‐fibroblast growth factor‐2 after intracerebral injection. Brain Res., 665, 285–292.
36.
De WinterF., OudegaM., LankhorstA.J., HamersF.P., BlitsB., RuitenbergM.J., PasterkampR.J., GispenW.H., and VerhaagenJ. (2002). Injury‐induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol., 175, 61–75.
37.
GrillR., MuraiK., BleschA., GageF.H., and TuszynskiM.H. (1997). Cellular delivery of neurotrophin‐3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci., 17, 5560–5572.
38.
LiuY., KimD., HimesB.T., ChowS.Y., SchallertT., MurrayM., TesslerA., and FischerI. (1999). Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci., 19, 4370–4387.
39.
TetzlaffW., AlexanderS.W., MillerF.D., and BisbyM.A. (1991). Response of facial and rubrospinal neurons to axotomy: changes in mRNA expression for cytoskeletal proteins and GAP‐43. J. Neurosci., 11, 2528–2544.
40.
KuchlerM., FouadK., WeinmannO., SchwabM.E., and RaineteauO. (2002). Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J. Comp. Neurol., 448, 349–359.
41.
MuirG.D., and WhishawI.Q. (2000). Red nucleus lesions impair overground locomotion in rats: a kinetic analysis. Eur. J. Neurosci., 12, 1113–1122.
42.
CizkovaD., RosochaJ., VanickyI., JergovaS., and CizekM. (2006). Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol. Neurobiol., 26, 1167–1180.
43.
DasariV.R., SpomarD.G., CadyC., GujratiM., RaoJ.S., and DinhD.H. (2007). Mesenchymal stem cells from rat bone marrow downregulate caspase‐3‐mediated apoptotic pathway after spinal cord injury in rats. Neurochem. Res., 32, 2080–2093.
44.
De UgarteD.A., AlfonsoZ., ZukP.A., ElbarbaryA., ZhuM., AshjianP., BenhaimP., HedrickM.H., and FraserJ.K. (2003). Differential expression of stem cell mobilization‐associated molecules on multi‐lineage cells from adipose tissue and bone marrow. Immunol. Lett., 89, 267–270.
45.
MiyazakiT., KitagawaY., ToriyamaK., KoboriM., and ToriiS. (2005). Isolation of two human fibroblastic cell populations with multiple but distinct potential of mesenchymal differentiation by ceiling culture of mature fat cells from subcutaneous adipose tissue. Differentiation, 73, 69–78.
46.
UccelliA., MorettaL., and PistoiaV. (2008). Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 8, 726–736.
47.
KanekoS., IwanamiA., NakamuraM., KishinoA., KikuchiK., ShibataS., OkanoH.J., IkegamiT., MoriyaA., KonishiO., NakayamaC., KumagaiK., KimuraT., SatoY., GoshimaY., TaniguchiM., ItoM., HeZ., ToyamaY., and OkanoH. (2006). A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med., 12, 1380–1389.
48.
RapalinoO., Lazarov‐SpieglerO., AgranovE., VelanG.J., YolesE., FraidakisM., SolomonA., GepsteinR., KatzA., BelkinM., HadaniM., and SchwartzM. (1998). Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med., 4, 814–821.
49.
MoalemG., Leibowitz‐AmitR., YolesE., MorF., CohenI.R., and SchwartzM. (1999). Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med., 5, 49–55.
